Effects of fullerenol C60(OH)22-24 on luminol- and lucigenin-dependent chemiluminescence of human leukocytes
Russian Journal of Immunology · 31.10.2026 · 29 (3) · 501-508
DOI: 10.46235/1028-7221-17381-eof ↗Kurz gefasst
Fachartikel in der Zeitschrift Russian Journal of Immunology, online erschienen am 31.10.2026. Verfasst von M. S. Bochkova und 5 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fullerenol C60(OH)22-24 is a promising fullerene derivative characterized by high water solubility, biocompatibility, and antioxidant properties. Despite extensive studies of its reactive oxygen species-scavenging effects in vitro and in vivo, its impact on the oxidative response of immune phagocytes remains unclear. This study aimed to assess reactive oxygen species production by human peripheral blood leukocytes exposed to fullerenol C60(OH)22-24 using luminol- and lucigenin-dependent chemiluminescence. Fullerenol C60(OH)22-24 (MST-WS60-Bio, 99.99% purity) formed monodisperse aggregates (~130 nm) with a zeta potential of -26±6.31 mV (mean±SD). Leukocytes (106/mL), isolated from healthy female donors (n = 4, aged 18-25 years) by sedimentation, were stimulated with opsonized zymosan (1.5 μg/mL). Fullerenol C60(OH)22-24 did not affect spontaneous luminol-dependent chemiluminescence at 30 and 60 minutes but nanoparticle’s high concentrations (50-200 μg/mL) reduced it after 90 minutes. In opsonized zymosan-stimulated luminol assays, inhibition occurred from 30 minutes across 5-200 μg/mL and persisted to 90 minutes (25-200 μg/ mL). Spontaneous lucigenin-dependent chemiluminescence remained unchanged, but opsonized zymosan-stimulated signals were suppressed from 12.5 to 200 μg/mL at 30-60 minutes, extending to 90 minutes at 50- 200 μg/mL. In cell-free H2O2 systems (0.039-0.625%) fullerenol did not quench either signal but enhanced luminol-dependent chemiluminescence (5-200 μg/mL), indicating peroxidase-like activity. Fullerenol C60(OH)22-24 (5-200 μg/mL) significantly suppresses luminol- and lucigenin-dependent chemiluminescence in stimulated human leukocytes, consistent with its antioxidant properties and suggesting superoxide dismutase- and/or catalase-like activity via hydroxyl hydrogen bonding and π-electron interactions.
Zitieren
APA
Bochkova, M. S., Timganova, V. P., Devyatova, K. O., Zamorina, S. A., Dolgikh, M. D., & Rayev, M. B. (2026). Effects of fullerenol C60(OH)22-24 on luminol- and lucigenin-dependent chemiluminescence of human leukocytes. Russian Journal of Immunology, 29(3), 501-508. https://doi.org/10.46235/1028-7221-17381-eof
Vancouver
Bochkova MS, Timganova VP, Devyatova KO, Zamorina SA, Dolgikh MD, Rayev MB. Effects of fullerenol C60(OH)22-24 on luminol- and lucigenin-dependent chemiluminescence of human leukocytes. Russian Journal of Immunology. 2026;29(3):501-508. doi:10.46235/1028-7221-17381-eof
BibTeX
@article{Bochkova2026,
author = {Bochkova, M. S. and Timganova, V. P. and Devyatova, K. O. and Zamorina, S. A. and Dolgikh, M. D. and Rayev, M. B.},
title = {Effects of fullerenol C60(OH)22-24 on luminol- and lucigenin-dependent chemiluminescence of human leukocytes},
journal = {Russian Journal of Immunology},
year = {2026},
volume = {29},
number = {3},
pages = {501--508},
doi = {10.46235/1028-7221-17381-eof}
}
EUVIMED